| Name | Bersiporocin |
|---|
| Description | Bersiporocin is a prolyl-tRNA synthetase inhibitor. Bersiporocin has an IC50 of ≤100 nM for phosphoribosylpyrophosphate synthetase (PRS). Bersiporocin can be used for the research of antifibrotic[1][2]. |
|---|---|
| Related Catalog | |
| Target |
PRS:≤100 nM (IC50) |
| References |
[2]. WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022. |
| Molecular Formula | C15H19Cl2N3O |
|---|---|
| Molecular Weight | 328.24 |